Cargando…

Insights Into SND1 Oncogene Promoter Regulation

The staphylococcal nuclease and Tudor domain containing 1 gene (SND1), also known as Tudor-SN, TSN or p100, encodes an evolutionarily conserved protein with invariant domain composition. SND1 contains four repeated staphylococcal nuclease domains and a single Tudor domain, which confer it endonuclea...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochoa, Begoña, Chico, Yolanda, Martínez, María José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297716/
https://www.ncbi.nlm.nih.gov/pubmed/30619748
http://dx.doi.org/10.3389/fonc.2018.00606
_version_ 1783381189011177472
author Ochoa, Begoña
Chico, Yolanda
Martínez, María José
author_facet Ochoa, Begoña
Chico, Yolanda
Martínez, María José
author_sort Ochoa, Begoña
collection PubMed
description The staphylococcal nuclease and Tudor domain containing 1 gene (SND1), also known as Tudor-SN, TSN or p100, encodes an evolutionarily conserved protein with invariant domain composition. SND1 contains four repeated staphylococcal nuclease domains and a single Tudor domain, which confer it endonuclease activity and extraordinary capacity for interacting with nucleic acids, individual proteins and protein complexes. Originally described as a transcriptional coactivator, SND1 plays fundamental roles in the regulation of gene expression, including RNA splicing, interference, stability, and editing, as well as in the regulation of protein and lipid homeostasis. Recently, SND1 has gained attention as a potential disease biomarker due to its positive correlation with cancer progression and metastatic spread. Such functional diversity of SND1 marks this gene as interesting for further analysis in relation with the multiple levels of regulation of SND1 protein production. In this review, we summarize the SND1 genomic region and promoter architecture, the set of transcription factors that can bind the proximal promoter, and the evidence supporting transactivation of SND1 promoter by a number of signal transduction pathways operating in different cell types and conditions. Unraveling the mechanisms responsible for SND1 promoter regulation is of utmost interest to decipher the SND1 contribution in the realm of both normal and abnormal physiology.
format Online
Article
Text
id pubmed-6297716
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62977162019-01-07 Insights Into SND1 Oncogene Promoter Regulation Ochoa, Begoña Chico, Yolanda Martínez, María José Front Oncol Oncology The staphylococcal nuclease and Tudor domain containing 1 gene (SND1), also known as Tudor-SN, TSN or p100, encodes an evolutionarily conserved protein with invariant domain composition. SND1 contains four repeated staphylococcal nuclease domains and a single Tudor domain, which confer it endonuclease activity and extraordinary capacity for interacting with nucleic acids, individual proteins and protein complexes. Originally described as a transcriptional coactivator, SND1 plays fundamental roles in the regulation of gene expression, including RNA splicing, interference, stability, and editing, as well as in the regulation of protein and lipid homeostasis. Recently, SND1 has gained attention as a potential disease biomarker due to its positive correlation with cancer progression and metastatic spread. Such functional diversity of SND1 marks this gene as interesting for further analysis in relation with the multiple levels of regulation of SND1 protein production. In this review, we summarize the SND1 genomic region and promoter architecture, the set of transcription factors that can bind the proximal promoter, and the evidence supporting transactivation of SND1 promoter by a number of signal transduction pathways operating in different cell types and conditions. Unraveling the mechanisms responsible for SND1 promoter regulation is of utmost interest to decipher the SND1 contribution in the realm of both normal and abnormal physiology. Frontiers Media S.A. 2018-12-11 /pmc/articles/PMC6297716/ /pubmed/30619748 http://dx.doi.org/10.3389/fonc.2018.00606 Text en Copyright © 2018 Ochoa, Chico and Martínez. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ochoa, Begoña
Chico, Yolanda
Martínez, María José
Insights Into SND1 Oncogene Promoter Regulation
title Insights Into SND1 Oncogene Promoter Regulation
title_full Insights Into SND1 Oncogene Promoter Regulation
title_fullStr Insights Into SND1 Oncogene Promoter Regulation
title_full_unstemmed Insights Into SND1 Oncogene Promoter Regulation
title_short Insights Into SND1 Oncogene Promoter Regulation
title_sort insights into snd1 oncogene promoter regulation
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297716/
https://www.ncbi.nlm.nih.gov/pubmed/30619748
http://dx.doi.org/10.3389/fonc.2018.00606
work_keys_str_mv AT ochoabegona insightsintosnd1oncogenepromoterregulation
AT chicoyolanda insightsintosnd1oncogenepromoterregulation
AT martinezmariajose insightsintosnd1oncogenepromoterregulation